{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T16:47:43Z","timestamp":1793119663195,"version":"4.5.0"},"reference-count":210,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303576"],"award-info":[{"award-number":["82303576"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Cutaneous squamous cell carcinoma (cSCC) is the second most common non-melanoma skin cancer, among which 82% arise from actinic keratosis (AK) characterized by lesions of epidermal keratinocyte dysplasia. It is of great significance to uncover the progression mechanisms from AK to cSCC, which will facilitate the early therapeutic intervention of AK before malignant transformation. Thus, more and more studies are trying to ascertain the potential transformation mechanisms through multi-omics, including genetics, transcriptomics, and epigenetics. In this review, we gave an overview of the specific biomarkers and signaling pathways that may be involved in the pathogenesis from AK to cSCC, pointing out future possible molecular therapies for the early intervention of AK and cSCC. We also discussed current interventions on AK and cSCC, together with future perspectives.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1518633","type":"journal-article","created":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T02:15:27Z","timestamp":1737684927000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":23,"title":["From actinic keratosis to cutaneous squamous cell carcinoma: the key pathogenesis and treatments"],"prefix":"10.3389","volume":"16","author":[{"given":"Zhenlin","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangqi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fujin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dekun","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lunhui","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guorong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guolong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3390\/biomedicines9020171","article-title":"Cutaneous squamous cell carcinoma: From pathophysiology to novel therapeutic approaches","volume":"9","author":"Fania","year":"2021","journal-title":"Biomedicines"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.3390\/cancers16101800","article-title":"Cutaneous squamous cell carcinoma: An updated review","volume":"16","author":"Jiang","year":"2024","journal-title":"Cancers (Basel)"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2015.1187","article-title":"Incidence estimate of nonmelanoma skin cancer (keratinocyte carcinomas) in the u.S. Population, 2012","volume":"151","author":"Rogers","year":"2015","journal-title":"JAMA Dermatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2012.11.037","article-title":"Cutaneous squamous cell carcinoma: Estimated incidence of disease, nodal metastasis, and deaths from disease in the United States, 2012","volume":"68","author":"Karia","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"B5","article-title":"retrospective analysis of 1905 patients with skin cancer from two general hospitals in western China from 1981 to 2000","volume":"36","author":"Gao","year":"2004","journal-title":"Beijing Da Xue Xue Bao Yi Xue Ban"},{"key":"B6","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ejca.2020.01.007","article-title":"European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 1. Epidemiology, diagnostics and prevention","volume":"128","author":"Stratigos","year":"2020","journal-title":"Eur J Cancer"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2013.2139","article-title":"Factors predictive of recurrence and death from cutaneous squamous cell carcinoma: A 10-year, single-institution cohort study","volume":"149","author":"Schmults","year":"2013","journal-title":"JAMA Dermatol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29436","article-title":"Survival after squamous cell and basal cell carcinoma of the skin: A retrospective cohort analysis","volume":"137","author":"Rees","year":"2015","journal-title":"Int J Cancer"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12420","article-title":"The natural history of actinic keratosis: A systematic review","volume":"169","author":"Werner","year":"2013","journal-title":"Br J Dermatol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24284","article-title":"Actinic keratoses: Natural history and risk of Malignant transformation in the veterans affairs topical tretinoin chemoprevention trial","volume":"115","author":"Criscione","year":"2009","journal-title":"Cancer"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12434","article-title":"Management of actinic keratosis: A practical report and treatment algorithm from akteam expert clinicians","volume":"28","author":"Dreno","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s13555-015-0070-9","article-title":"Primary care review of actinic keratosis and its therapeutic options: A global perspective","volume":"5","author":"Chetty","year":"2015","journal-title":"Dermatol Ther (Heidelb)"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.14147","article-title":"Actinic keratosis - review for clinical practice","volume":"58","author":"de Oliveira","year":"2019","journal-title":"Int J Dermatol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2013.134","article-title":"Prevalence of actinic keratosis and its risk factors in the general population:\u00a0The rotterdam study","volume":"133","author":"Flohil","year":"2013","journal-title":"J Invest Dermatol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1684\/ejd.2017.3126","article-title":"Prevalence and risk factors of actinic keratosis in patients attending italian dermatology clinics","volume":"27","author":"Fargnoli","year":"2017","journal-title":"Eur J Dermatol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-021-00644-3","article-title":"Exposome and skin. Part 2. The influential role of the exposome, beyond uvr, in actinic keratosis, bowen\u2019s disease and squamous cell carcinoma: A proposal","volume":"12","author":"Molina-Garcia","year":"2022","journal-title":"Dermatol Ther (Heidelb)"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdin.2023.02.003","article-title":"Identifying risk factors for cutaneous disease among solid organ transplant recipients: A retrospective review","volume":"11","author":"Shope","year":"2023","journal-title":"JAAD Int"},{"key":"B18","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/j.1365-2133.2009.09453.x","article-title":"Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: A 24 months, prospective, case-control study","author":"Ulrich","year":"2009","journal-title":"Br J Dermatol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2010.11.062","article-title":"Skin cancer in solid organ transplant recipients: Advances in therapy and management: Part i. Epidemiology of skin cancer in solid organ transplant recipients","volume":"65","author":"O\u2019Reilly Zwald","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1684\/ejd.2013.1923","article-title":"Therapeutic strategies for actinic keratoses\u2013a systematic review","volume":"23","author":"Nashan","year":"2013","journal-title":"Eur J Dermatol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2016.02.804","article-title":"Prevalence of skin cancer and related skin tumors in high-risk kidney and liver transplant recipients in queensland, Australia","volume":"136","author":"Iannacone","year":"2016","journal-title":"J Invest Dermatol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.02.082","article-title":"Guidelines of care for the management of actinic keratosis","volume":"85","author":"Eisen","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199310143291602","article-title":"Reduction of solar keratoses by regular\u00a0sunscreen use","volume":"329","author":"Thompson","year":"1993","journal-title":"N Engl J Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.139.4.451","article-title":"A randomized controlled trial to assess sunscreen application and beta carotene supplementation in the prevention of solar keratoses","volume":"139","author":"Darlington","year":"2003","journal-title":"Arch Dermatol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2010.09659.x","article-title":"Randomized, double-blinded, placebo controlled study to assess the effect of topical 1% nicotinamide on actinic keratoses","volume":"162","author":"Moloney","year":"2010","journal-title":"Br J Dermatol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2011.459","article-title":"Oral nicotinamide reduces actinic keratoses in phase ii double-blinded randomized controlled trials","volume":"132","author":"Surjana","year":"2012","journal-title":"J Invest Dermatol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1506197","article-title":"A phase 3 randomized trial of nicotinamide for skin-cancer chemoprevention","volume":"373","author":"Chen","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1995.13.8.1933","article-title":"Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: A double-blind, placebo-controlled study","volume":"13","author":"Bavinck","year":"1995","journal-title":"J Clin Oncol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1097\/DSS.0000000000002423","article-title":"Efficacy and cost analysis for acitretin for basal and squamous cell carcinoma prophylaxis in renal transplant recipients","volume":"47","author":"Badri","year":"2021","journal-title":"Dermatol Surg"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2023.06.016","article-title":"Oral nicotinamide for actinic keratosis prevention in kidney transplant recipients: A pilot double-blind, randomized, placebo-controlled trial","volume":"55","author":"Zhang","year":"2023","journal-title":"Transplant Proc"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e13726","DOI":"10.1111\/srt.13726","article-title":"Evaluation and treatment monitoring of actinic keratosis using line-field confocal optical coherence tomography","volume":"30","author":"Pathak","year":"2024","journal-title":"Skin Res Technol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/biomedicines6010008","article-title":"Actinic keratosis and non-invasive diagnostic techniques: An update","volume":"6","author":"Casari","year":"2018","journal-title":"Biomedicines"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1111\/srt.13028","article-title":"High-frequency ultrasound in the diagnosis of the spectrum of cutaneous squamous cell carcinoma: Noninvasively distinguishing actinic keratosis, bowen\u2019s disease, and invasive squamous cell carcinoma","volume":"27","author":"Zhu","year":"2021","journal-title":"Skin Res Technol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2012.1060","article-title":"Validation of dermoscopy as a real-time noninvasive diagnostic imaging technique for actinic keratosis","volume":"148","author":"Huerta-Brogeras","year":"2012","journal-title":"Arch Dermatol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ad.2024.03.023","article-title":"Dermoscopy of squamous cell carcinoma: From actinic keratosis to invasive forms","volume":"115","author":"Alvarez-Salafranca","year":"2024","journal-title":"Actas Dermosifiliogr"},{"key":"B36","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1159\/000366541","article-title":"Reflectance confocal microscopy: Hallmarks of keratinocyte cancer and its precursors","volume":"46","author":"Prow","year":"2015","journal-title":"Curr Probl Dermatol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2000.103344","article-title":"Histopathology of incipient intraepidermal squamous cell carcinoma (\u201cactinic keratosis\u201d)","volume":"42","author":"Cockerell","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2023.0056","article-title":"Basal cell skin cancer, version 2.2024, nccn clinical practice guidelines in oncology","volume":"21","author":"Schmults","year":"2023","journal-title":"J Natl Compr Canc Netw"},{"key":"B39","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/sj.jidsp.5640173","article-title":"Ultraviolet radiation induced signature mutations in photocarcinogenesis","volume":"4","author":"Wikonkal","year":"1999","journal-title":"J Investig Dermatol Symp Proc"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2014.762","article-title":"Incidence of nonmelanoma skin cancer in relation to ambient uv radiation in white populations, 1978-2012: Empirical relationships","volume":"150","author":"Xiang","year":"2014","journal-title":"JAMA Dermatol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/s0190-9622(99)70185-4","article-title":"Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens","volume":"40","author":"Jensen","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199003000-00006","article-title":"Incidence of skin cancer after renal transplantation in the Netherlands","volume":"49","author":"Hartevelt","year":"1990","journal-title":"Transplantation"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2000.03703.x","article-title":"Incidence of skin cancer in 5356 patients following organ transplantation","volume":"143","author":"Lindelof","year":"2000","journal-title":"Br J Dermatol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2008.11.046","article-title":"Papillomaviruses in the causation of human cancers - a brief historical account","volume":"384","author":"Zur Hausen","year":"2009","journal-title":"Virology"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2008.03547.x","article-title":"Multiple cutaneous precanceroses and carcinomas from combined iatrogenic\/professional exposure to arsenic","volume":"47","author":"Torchia","year":"2008","journal-title":"Int J Dermatol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.1989.01410010125024","article-title":"Squamous cell carcinoma arising in previously burned or irradiated skin","volume":"124","author":"Edwards","year":"1989","journal-title":"Arch Surg"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.35541\/cjd.20201140","article-title":"Expert consensus on the diagnosis and treatment of cutaneous squamous cell carcinoma (2021)","year":"2021","journal-title":"Chin J Dermatol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2023.113251","article-title":"European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma. Part 1: Diagnostics and prevention-update 2023","volume":"193","author":"Stratigos","year":"2023","journal-title":"Eur J Cancer"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jid.5701058","article-title":"Uv radiation-induced immunosuppression is greater in men and prevented by topical nicotinamide","volume":"128","author":"Damian","year":"2008","journal-title":"J Invest Dermatol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2203086","article-title":"Nicotinamide for skin-cancer chemoprevention in transplant recipients","volume":"388","author":"Allen","year":"2023","journal-title":"N Engl J Med"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1067\/s0190-9622(03)01587-1","article-title":"Oral retinoid use reduces cutaneous squamous cell carcinoma risk in patients with psoriasis treated with psoralen-uva: A nested cohort study","volume":"49","author":"Nijsten","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12519","article-title":"Systemic retinoids for the chemoprevention of cutaneous squamous cell carcinoma and verrucal keratosis in a cohort of patients on braf inhibitors","volume":"169","author":"Anforth","year":"2013","journal-title":"Br J Dermatol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.det.2019.02.004","article-title":"Topical and systemic modalities for chemoprevention of nonmelanoma skin cancer","volume":"37","author":"Nemer","year":"2019","journal-title":"Dermatol Clin"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29357","article-title":"Nonsteroidal anti-inflammatory drugs and the risk of nonmelanoma skin cancer","volume":"137","author":"Reinau","year":"2015","journal-title":"Int J Cancer"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2009.10.044","article-title":"Digital squamous cell carcinoma and association with diverse high-risk human papillomavirus types","volume":"64","author":"Gormley","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.08.059","article-title":"Cutaneous squamous cell carcinoma: Incidence, risk factors, diagnosis, and staging","volume":"78","author":"Que","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3390\/biomedicines5040071","article-title":"Histology of non-melanoma skin cancers: An update","volume":"5","author":"Paolino","year":"2017","journal-title":"Biomedicines"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.5826\/dpc.1003a66","article-title":"Squamous cell carcinoma: An update on diagnosis and treatment","volume":"10","author":"Combalia","year":"2020","journal-title":"Dermatol Pract Concept"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.4103\/idoj.idoj_257_21","article-title":"Bowen\u2019s disease","volume":"13","author":"Palaniappan","year":"2022","journal-title":"Indian Dermatol Online J"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2009.134","article-title":"Reflectance confocal microscopy criteria for squamous cell carcinomas and actinic keratoses","volume":"145","author":"Rishpon","year":"2009","journal-title":"Arch Dermatol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1093\/bjd\/ljad174.002","article-title":"O02 neoantigens from actinic keratosis are predicted to be more immunogenic than those from cutaneous squamous cell carcinoma \u2013 a strategy for immune escape","volume":"189","author":"Jason Thomson","year":"2023","journal-title":"Br J Dermatol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3390\/biology9090285","article-title":"A glance of p53 functions in brain development, neural stem cells, and brain cancer","volume":"9","author":"Xiong","year":"2020","journal-title":"Biol (Basel)"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.593383","article-title":"Heterogeneity of tp53 mutations and p53 protein residual function in cancer: Does it matter","volume":"10","author":"Monti","year":"2020","journal-title":"Front Oncol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.30222","article-title":"Tp53 mutations are early events in chronic lymphocytic leukemia disease progression and precede evolution to complex karyotypes","volume":"139","author":"Lazarian","year":"2016","journal-title":"Int J Cancer"},{"key":"B65","doi-asserted-by":"publisher","first-page":"4507","DOI":"10.3390\/cancers13184507","article-title":"The role of p53 in progression of cutaneous squamous cell carcinoma","volume":"13","author":"Piipponen","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B66","doi-asserted-by":"publisher","first-page":"3478","DOI":"10.3390\/ijms23073478","article-title":"Molecular mechanisms of cutaneous squamous cell carcinoma","volume":"23","author":"Hedberg","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1111\/exd.14730","article-title":"Targeted deep sequencing reveals genomic alterations of actinic keratosis\/cutaneous squamous cell carcinoma in situ and cutaneous squamous cell carcinoma","volume":"32","author":"Kim","year":"2023","journal-title":"Exp Dermatol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3835(94)90234-8","article-title":"Analysis of the p53 gene in human precancerous actinic keratosis lesions and squamous cell cancers","volume":"85","author":"Nelson","year":"1994","journal-title":"Cancer Lett"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/s0092-8674(00)81871-1","article-title":"P53, the cellular gatekeeper for growth and division","volume":"88","author":"Levine","year":"1997","journal-title":"Cell"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1177\/030089160409000124","article-title":"P53 protein expression and cell proliferation in non-neoplastic and neoplastic proliferative skin diseases","volume":"90","author":"Batinac","year":"2004","journal-title":"Tumori"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-005-0532-7","article-title":"Early cancers of the skin: Clinical, histopathological, and molecular characteristics","volume":"10","author":"Takata","year":"2005","journal-title":"Int J Clin Oncol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1038\/372773a0","article-title":"Sunburn and p53 in the onset of skin cancer","volume":"372","author":"Ziegler","year":"1994","journal-title":"Nature"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12395643","article-title":"Aberrations of the tumor suppressor p53 gene and p53 protein in solar keratosis in\u00a0human skin","volume":"103","author":"Taguchi","year":"1994","journal-title":"J Invest Dermatol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1002\/path.4770","article-title":"Cdkn2a suppresses metastasis in squamous cell carcinomas induced by the gain-of-function mutant p53(r172h)","volume":"240","author":"Li","year":"2016","journal-title":"J Pathol"},{"key":"B75","first-page":"1091","article-title":"The evolution of tp53 mutations: From loss-of-function to separation-of-function mutants","volume":"4","author":"Miller","year":"2016","journal-title":"J Cancer Biol Res"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1321640111","article-title":"P53psi is\u00a0a\u00a0transcriptionally inactive p53 isoform able to reprogram cells toward a metastatic-like state","volume":"111","author":"Senturk","year":"2014","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.17929","article-title":"Tp53 exon-6 truncating mutations produce separation of function isoforms with pro-tumorigenic functions","volume":"5","author":"Shirole","year":"2016","journal-title":"Elife"},{"key":"B78","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.ccr.2006.12.013","article-title":"P38alpha map kinase as a sensor of reactive oxygen species in tumorigenesis","volume":"11","author":"Dolado","year":"2007","journal-title":"Cancer Cell"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(94)90278-x","article-title":"Interleukin-1 activates a novel protein kinase cascade that results in the phosphorylation of hsp27","volume":"78","author":"Freshney","year":"1994","journal-title":"Cell"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1126\/science.7914033","article-title":"A map kinase targeted by endotoxin and hyperosmolarity in mammalian cells","volume":"265","author":"Han","year":"1994","journal-title":"Science"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1038\/emboj.2011.69","article-title":"P38mapk is a novel DNA damage response-independent regulator of the senescence-associated secretory phenotype","volume":"30","author":"Freund","year":"2011","journal-title":"EMBO J"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-020-03539-2","article-title":"Tp63 links chromatin remodeling and enhancer reprogramming to epidermal differentiation and squamous cell carcinoma development","volume":"77","author":"Yi","year":"2020","journal-title":"Cell Mol Life Sci"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1038\/372739a0","article-title":"A protein kinase involved in the regulation of inflammatory cytokine biosynthesis","volume":"372","author":"Lee","year":"1994","journal-title":"Nature"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1038\/nature08467","article-title":"The DNA-damage response in human biology and disease","volume":"461","author":"Jackson","year":"2009","journal-title":"Nature"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aau0727","article-title":"The protein kinase p38alpha destabilizes p63 to limit epidermal stem cell frequency and tumorigenic potential","volume":"11","author":"Choo","year":"2018","journal-title":"Sci Signal"},{"key":"B86","doi-asserted-by":"publisher","first-page":"325","DOI":"10.4103\/0019-5154.113935","article-title":"Reduced p53 staining in actinic keratosis is associated with squamous cell carcinoma: A preliminary study","volume":"58","author":"Neto","year":"2013","journal-title":"Indian J Dermatol"},{"key":"B87","article-title":"P53 from basic research to clinical applications","volume":"3","author":"Tominaga","year":"1992","journal-title":"Crit Rev Oncog"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/42.6.858","article-title":"Biological and clinical importance of the p53 tumor suppressor gene","volume":"42","author":"Velculescu","year":"1996","journal-title":"Clin Chem"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cdd.4401921","article-title":"Strategies for therapeutic targeting of the p53 pathway in cancer","volume":"13","author":"Wiman","year":"2006","journal-title":"Cell Death Differ"},{"key":"B90","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jbior.2016.10.001","article-title":"Roles of tp53 in determining therapeutic sensitivity, growth, cellular senescence, invasion and metastasis","volume":"63","author":"McCubrey","year":"2017","journal-title":"Adv Biol Regul"},{"key":"B91","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1111\/bjd.18338","article-title":"The clinical course of actinic keratosis correlates with underlying molecular mechanisms","volume":"182","author":"Bakshi","year":"2020","journal-title":"Br J Dermatol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1006\/geno.1994.1613","article-title":"The human notch1, 2, and 3 genes are located at chromosome positions 9q34, 1p13-p11, and 19p13.2-p13.1 in regions of neoplasia-associated translocation","volume":"24","author":"Larsson","year":"1994","journal-title":"Genomics"},{"key":"B93","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ccr.2009.05.016","article-title":"Epidermal notch1 loss promotes skin tumorigenesis by impacting the stromal microenvironment","volume":"16","author":"Demehri","year":"2009","journal-title":"Cancer Cell"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1114669108","article-title":"Loss-of-function mutations in notch receptors in cutaneous and lung squamous cell carcinoma","volume":"108","author":"Wang","year":"2011","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0811-x","article-title":"Age-related remodelling of oesophageal epithelia by mutated cancer drivers","volume":"565","author":"Yokoyama","year":"2019","journal-title":"Nature"},{"key":"B96","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.jid.2020.05.116","article-title":"Whole-exome and transcriptome analysis of uv-exposed epidermis and carcinoma in situ reveals early drivers of carcinogenesis","volume":"141","author":"Zheng","year":"2021","journal-title":"J Invest Dermatol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.jid.2021.07.172","article-title":"Genomic progression of precancerous actinic keratosis to squamous cell carcinoma","volume":"142","author":"Kim","year":"2022","journal-title":"J Invest Dermatol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1016\/j.jid.2020.12.024","article-title":"The genomic landscape of actinic keratosis","volume":"141","author":"Thomson","year":"2021","journal-title":"J Invest Dermatol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaa6806","article-title":"Tumor evolution. High burden and pervasive positive selection of somatic mutations in normal human skin","volume":"348","author":"Martincorena","year":"2015","journal-title":"Science"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2014.154","article-title":"Notch1 mutations occur early during cutaneous squamous cell carcinogenesis","volume":"134","author":"South","year":"2014","journal-title":"J Invest Dermatol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1177\/0022034518760297","article-title":"The notch pathway in head and neck squamous cell carcinoma","volume":"97","author":"Fukusumi","year":"2018","journal-title":"J Dent Res"},{"key":"B102","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41392-022-00934-y","article-title":"Notch signaling pathway: Architecture, disease, and therapeutics","volume":"7","author":"Zhou","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-1366","article-title":"The notch4-hey1 pathway induces epithelial-mesenchymal transition in head and neck squamous cell carcinoma","volume":"24","author":"Fukusumi","year":"2018","journal-title":"Clin Cancer Res"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2021.103403","article-title":"Notch signaling: Journey of an evolutionarily conserved pathway in driving tumor progression and its modulation as a therapeutic target","volume":"164","author":"Aggarwal","year":"2021","journal-title":"Crit Rev Oncol Hematol"},{"key":"B105","doi-asserted-by":"publisher","first-page":"431","DOI":"10.3390\/molecules23020431","article-title":"Taming the notch transcriptional regulator for cancer therapy","volume":"23","author":"Tamagnone","year":"2018","journal-title":"Molecules"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djm148","article-title":"Notch emerges as new cancer drug target","volume":"99","author":"Garber","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.2174\/156800906777441771","article-title":"Notch signaling as a novel cancer therapeutic target","volume":"6","author":"Miele","year":"2006","journal-title":"Curr Cancer Drug Targets"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1002\/cncy.22701","article-title":"Cdkn2a\/p16 evaluation in cytology specimens","volume":"131","author":"Xing","year":"2023","journal-title":"Cancer Cytopathol"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1111\/j.0022-202X.2004.22501.x","article-title":"P16ink4a and p14arf tumor suppressor genes are commonly inactivated in cutaneous squamous cell carcinoma","volume":"122","author":"Brown","year":"2004","journal-title":"J Invest Dermatol"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1038\/35096061","article-title":"The ink4a\/arf network in tumour suppression","volume":"2","author":"Sherr","year":"2001","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s12967-019-1977-1","article-title":"Type 1 diabetic mellitus patients with increased atherosclerosis risk display decreased cdkn2a\/2b\/2bas gene expression in leukocytes","volume":"17","author":"Martinez-Hervas","year":"2019","journal-title":"J Transl Med"},{"key":"B112","doi-asserted-by":"publisher","first-page":"3667","DOI":"10.1038\/s41467-018-06027-1","article-title":"The\u00a0genomic landscape of cutaneous scc reveals drivers and a novel azathioprine associated mutational signature","volume":"9","author":"Inman","year":"2018","journal-title":"Nat Commun"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1016\/s0304-3835(01)00757-1","article-title":"Progression of actinic keratosis to squamous cell carcinoma of the skin correlates with deletion of the 9p21 region encoding the p16(ink4a) tumor suppressor","volume":"176","author":"Mortier","year":"2002","journal-title":"Cancer Lett"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.9745\/GHSP-D-16-00130","article-title":"Moving medicine, moving minds: Helping developing countries overcome barriers to outsourcing health commodity distribution to boost supply chain performance and strengthen health systems","volume":"4","author":"Agrawal","year":"2016","journal-title":"Glob Health Sci Pract"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2008.01.042","article-title":"Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(arf), p15(ink4b), p16(ink4a) and p53 in actinic keratosis","volume":"264","author":"Kanellou","year":"2008","journal-title":"Cancer Lett"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2002.01785.x","article-title":"Inactivation of tumor suppressor genes p15(ink4b) and p16(ink4a) in primary cutaneous b cell lymphoma","volume":"118","author":"Child","year":"2002","journal-title":"J Invest Dermatol"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/23.4.645","article-title":"Genetic status of cell cycle regulators in squamous cell carcinoma of the oesophagus: The cdkn2a (p16(ink4a) and p14(arf)) and p53 genes are major targets for inactivation","volume":"23","author":"Smeds","year":"2002","journal-title":"Carcinogenesis"},{"key":"B118","doi-asserted-by":"publisher","first-page":"19","DOI":"10.47162\/RJME.65.1.03","article-title":"Immunoexpression of ki67, p16 and beta-catenin in precursor lesions of cutaneous squamous cell carcinoma","volume":"65","author":"Vilcea","year":"2024","journal-title":"Rom J Morphol Embryol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.24871","article-title":"Cdkn2a but not tp53 mutations nor hpv presence predict poor outcome in metastatic squamous cell carcinoma of the skin","volume":"126","author":"Kusters-Vandevelde","year":"2010","journal-title":"Int J Cancer"},{"key":"B120","doi-asserted-by":"publisher","first-page":"e33468","DOI":"10.1097\/MD.0000000000033468","article-title":"Comprehensive analyses of cuproptosis-related gene cdkn2a on prognosis and immunologic therapy in human tumors","volume":"102","author":"Zhang","year":"2023","journal-title":"Med (Baltimore)"},{"key":"B121","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1186\/s12885-023-11603-w","article-title":"High expression of cdkn2a is associated with poor prognosis in colorectal cancer and may guide pd-1-mediated immunotherapy","volume":"23","author":"Dong","year":"2023","journal-title":"BMC Cancer"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1200\/PO.23.00053","article-title":"Patterns of treatment failure after selective rearranged during transfection (ret) inhibitors in patients with metastatic medullary thyroid carcinoma","volume":"7","author":"Hadoux","year":"2023","journal-title":"JCO Precis Oncol"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(85)90115-1","article-title":"Activation of a novel human transforming gene, ret, by DNA rearrangement","volume":"42","author":"Takahashi","year":"1985","journal-title":"Cell"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-22-0047","article-title":"Mab21l4 deficiency drives squamous cell carcinoma via activation of ret","volume":"82","author":"Srivastava","year":"2022","journal-title":"Cancer Res"},{"key":"B125","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1093\/jb\/mvab141","article-title":"Mab21l4 regulates the tgf-beta-induced expression of target genes in epidermal keratinocytes","volume":"171","author":"Ogami","year":"2022","journal-title":"J Biochem"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-022-04497-x","article-title":"Cacybp knockdown inhibits progression of prostate cancer via p53","volume":"149","author":"Li","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1080\/13543776.2022.2132851","article-title":"An updated patent review of rearranged during transfection (ret) kinase inhibitors (2016-present)","volume":"32","author":"Acharya","year":"2022","journal-title":"Expert Opin Ther Pat"},{"key":"B128","doi-asserted-by":"publisher","first-page":"8839","DOI":"10.3390\/molecules27248839","article-title":"Precious gene: The application of ret-altered inhibitors","volume":"27","author":"Gou","year":"2022","journal-title":"Molecules"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2021.07.003","article-title":"Precision therapy for ret-altered cancers with ret inhibitors","volume":"7","author":"Thein","year":"2021","journal-title":"Trends Cancer"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.0c02167","article-title":"Targeting rearranged during transfection in cancer: A perspective on small-molecule inhibitors and their clinical development","volume":"64","author":"Saha","year":"2021","journal-title":"J Med Chem"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.20517\/cdr.2020.15","article-title":"Ret kinase alterations in targeted cancer therapy","volume":"3","author":"Liu","year":"2020","journal-title":"Cancer Drug Resist"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.2174\/138161213804547240","article-title":"Inhibition of ret activated pathways: Novel strategies for therapeutic intervention in human cancers","volume":"19","author":"Santarpia","year":"2013","journal-title":"Curr Pharm Des"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1038\/35044005","article-title":"The DNA damage response: Putting checkpoints in perspective","volume":"408","author":"Zhou","year":"2000","journal-title":"Nature"},{"key":"B134","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/cr.2014.147","article-title":"Rpa-coated single-stranded DNA as a platform for post-translational modifications in the DNA damage response","volume":"25","author":"Marechal","year":"2015","journal-title":"Cell Res"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1101\/2024.01.29.577821","article-title":"An ahr-ovol1-id1 regulatory axis in keratinocytes promotes skin homeostasis against atopic dermatitis","author":"Chen","year":"2024","journal-title":"bioRxiv"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2023.05.008","article-title":"Ovol2: An epithelial lineage determiner with emerging roles in energy homeostasis","volume":"33","author":"Jiang","year":"2023","journal-title":"Trends Cell Biol"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1006\/geno.2002.6831","article-title":"Ovol2, a mammalian homolog of drosophila ovo: Gene structure, chromosomal mapping, and aberrant expression in blind-sterile mice","volume":"80","author":"Li","year":"2002","journal-title":"Genomics"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0076773","article-title":"Transcription factors ovol1 and ovol2 induce the mesenchymal to epithelial transition in human cancer","volume":"8","author":"Roca","year":"2013","journal-title":"PloS One"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.7150\/thno.24003","article-title":"Ovol2 links stemness and metastasis via fine-tuning epithelial-mesenchymal transition in nasopharyngeal carcinoma","volume":"8","author":"Qi","year":"2018","journal-title":"Theranostics"},{"key":"B140","doi-asserted-by":"publisher","first-page":"618","DOI":"10.3390\/jcm9030618","article-title":"Ovol2-mediated zeb1 downregulation may prevent promotion of actinic keratosis to cutaneous squamous cell carcinoma","volume":"9","author":"Murata","year":"2020","journal-title":"J Clin Med"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.4161\/cc.8.17.9514","article-title":"Skap associates with kinetochores and promotes the metaphase-to-anaphase transition","volume":"8","author":"Fang","year":"2009","journal-title":"Cell Cycle"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/6729717","article-title":"Knstrn, a poor prognostic biomarker, affects the tumor immune microenvironment and immunotherapy outcomes in pan-cancer","volume":"2023","author":"Zhang","year":"2023","journal-title":"Dis Markers"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3091","article-title":"Recurrent point mutations in the kinetochore gene knstrn in cutaneous squamous cell carcinoma","volume":"46","author":"Lee","year":"2014","journal-title":"Nat Genet"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15615","article-title":"Somatic mutations in kinetochore gene knstrn are associated with basal proliferating actinic keratoses and cutaneous squamous cell carcinoma","volume":"33","author":"Schmitz","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B145","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.bbalip.2004.11.012","article-title":"Characterization of a ceramide kinase-like protein","volume":"1687","author":"Bornancin","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1111\/aos.13551","article-title":"A founder mutation in cerkl is a major cause of retinal dystrophy in Finland","volume":"96","author":"Avela","year":"2018","journal-title":"Acta Ophthalmol"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2018.01.008","article-title":"Head and neck squamous cell carcinoma: Genomics and emerging biomarkers for immunomodulatory cancer treatments","volume":"52","author":"Solomon","year":"2018","journal-title":"Semin Cancer Biol"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2018.1520548","article-title":"Cerkl regulates autophagy via the nad-dependent deacetylase sirt1","volume":"15","author":"Hu","year":"2019","journal-title":"Autophagy"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000022257","article-title":"Identification of potential gene drivers of cutaneous squamous cell carcinoma: Analysis of microarray data","volume":"99","author":"Zheng","year":"2020","journal-title":"Med (Baltimore)"},{"key":"B150","article-title":"A biologically important single nucleotide polymorphism within the toll-like receptor-4 gene is not associated with rheumatoid arthritis","volume":"21","author":"Kilding","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0185668","article-title":"Tlr4 as a negative regulator of keratinocyte proliferation","volume":"12","author":"Iotzova-Weiss","year":"2017","journal-title":"PloS One"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006092","article-title":"The tir homologue lies near resistance genes in staphylococcus aureus, coupling modulation of virulence and antimicrobial susceptibility","volume":"13","author":"Patot","year":"2017","journal-title":"PloS Pathog"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2019.4790","article-title":"Toll\u2212like receptor 4 plays a tumor\u2212suppressive role in cutaneous squamous cell carcinoma","volume":"54","author":"Mikami","year":"2019","journal-title":"Int J Oncol"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.2174\/0929867324666170828125328","article-title":"Tlr4-directed molecular strategies targeting skin photodamage and carcinogenesis","volume":"25","author":"Dickinson","year":"2018","journal-title":"Curr Med Chem"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00135","article-title":"Toll-like receptors and skin cancer","volume":"5","author":"Burns","year":"2014","journal-title":"Front Immunol"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-540-72167-3_10","article-title":"Toll-like receptor-agonists in the treatment of skin cancer: History, current developments and future prospects","volume":"183","author":"Wenzel","year":"2008","journal-title":"Handb Exp Pharmacol"},{"key":"B157","article-title":"Structure and regulation of the c1 inhibitor gene","volume":"93","author":"Zahedi","year":"1993","journal-title":"Behring Inst Mitt"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1718709115","article-title":"Structure of the c1r-c1s interaction of the c1 complex of complement activation","volume":"115","author":"Almitairi","year":"2018","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1311113110","article-title":"Structural basis of the c1q\/c1s interaction and its central role in assembly of the c1 complex of complement activation","volume":"110","author":"Venkatraman Girija","year":"2013","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.18095","article-title":"Tumour-cell-derived complement components c1r and c1s promote growth of cutaneous squamous cell carcinoma","volume":"182","author":"Riihila","year":"2020","journal-title":"Br J Dermatol"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1923","article-title":"Complement: A key system for immune surveillance and homeostasis","volume":"11","author":"Ricklin","year":"2010","journal-title":"Nat Immunol"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10587","article-title":"Structural basis of complement membrane attack complex formation","volume":"7","author":"Serna","year":"2016","journal-title":"Nat Commun"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01308","article-title":"Complement nomenclature-deconvoluted","volume":"10","author":"Bohlson","year":"2019","journal-title":"Front Immunol"},{"key":"B164","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3390\/cancers14020305","article-title":"Complement factor d is a novel biomarker and putative therapeutic target in cutaneous squamous cell carcinoma","volume":"14","author":"Rahmati Nezhad","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1007\/s13577-022-00752-y","article-title":"Long non\u2212coding rna part1: Dual role in cancer","volume":"35","author":"Ran","year":"2022","journal-title":"Hum Cell"},{"key":"B166","doi-asserted-by":"publisher","first-page":"79","DOI":"10.21037\/atm-21-6916","article-title":"Downregulation of lncrna neat1 inhibits the proliferation of human cutaneous squamous cell carcinoma","volume":"10","author":"Gong","year":"2022","journal-title":"Vivo vitro. Ann Transl Med"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105764","article-title":"Combination lsd1 and\u00a0hotair-ezh2 inhibition disrupts cell cycle processes and induces apoptosis in\u00a0glioblastoma cells","volume":"171","author":"Zhao","year":"2021","journal-title":"Pharmacol Res"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.21037\/tcr-22-842","article-title":"Whole-genome identification and construction of the lncrna-mrna co-expression network in patients with actinic keratosis","volume":"11","author":"Luan","year":"2022","journal-title":"Transl Cancer Res"},{"key":"B169","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1146\/annurev.pathol.4.110807.092222","article-title":"Micrornas in cancer","volume":"4","author":"Lee","year":"2009","journal-title":"Annu Rev Pathol"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.4161\/cc.7.5.5547","article-title":"Micrornas in Malignant progression","volume":"7","author":"Ma","year":"2008","journal-title":"Cell Cycle"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2008.274","article-title":"Micrornas: Key players in the immune system, differentiation, tumorigenesis and cell death","volume":"27","author":"Schickel","year":"2008","journal-title":"Oncogene"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2017.315","article-title":"Alterations of micrornas throughout the Malignant evolution of cutaneous squamous cell carcinoma: The role of mir-497 in epithelial to mesenchymal transition of keratinocytes","volume":"37","author":"Mizrahi","year":"2018","journal-title":"Oncogene"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.14131","article-title":"Pathogenic genes related to the progression of actinic keratoses to cutaneous squamous cell carcinoma","volume":"57","author":"Zhang","year":"2018","journal-title":"Int J Dermatol"},{"key":"B174","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.3390\/biomedicines11061719","article-title":"Micrornas differentially expressed in actinic keratosis and healthy skin scrapings","volume":"11","author":"Chiantore","year":"2023","journal-title":"Biomedicines"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-021-02221-2","article-title":"Profiling of micrornas in actinic keratosis and cutaneous squamous cell carcinoma patients","volume":"314","author":"Danczak-Pazdrowska","year":"2022","journal-title":"Arch Dermatol Res"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-016-0537-z","article-title":"Mir-204 silencing in intraepithelial to invasive cutaneous squamous cell carcinoma progression","volume":"15","author":"Toll","year":"2016","journal-title":"Mol Cancer"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2023.05.026","article-title":"Microrna-23b plays a tumor-suppressive role in cutaneous squamous cell carcinoma and targets ras-related protein rras2","volume":"143","author":"Sun","year":"2023","journal-title":"J Invest Dermatol"},{"key":"B178","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1016\/j.jid.2021.09.040","article-title":"Mir-181a promotes multiple protumorigenic functions by targeting tgfbetar3","volume":"142","author":"Chitsazzadeh","year":"2022","journal-title":"J Invest Dermatol"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-021-02288-x","article-title":"Microrna31 and mmp-1 contribute to the differentiated pathway of invasion -with enhanced epithelial-to-mesenchymal transition- in squamous cell carcinoma of the skin","volume":"314","author":"Fernandez-Figueras","year":"2022","journal-title":"Arch Dermatol Res"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1111\/exd.13902","article-title":"Topical kinase inhibitors induce regression of cutaneous squamous cell carcinoma","volume":"28","author":"Yang","year":"2019","journal-title":"Exp Dermatol"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.5826\/dpc.1302a151","article-title":"Real-world experience with topical 5-fluorouracil 4% (40 mg\/g) cream for the treatment of actinic keratosis","volume":"13","author":"Briatico","year":"2023","journal-title":"Dermatol Pract Concept"},{"key":"B182","doi-asserted-by":"publisher","first-page":"2956","DOI":"10.3390\/cancers15112956","article-title":"Actinic keratoses: A prospective pilot study on a novel formulation of 4% 5-fluorouracil cream and a review of other current topical treatment options","volume":"15","author":"Toffoli","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-2020","article-title":"5-fluorouracil enhances protoporphyrin ix accumulation and lesion clearance during photodynamic therapy of actinic keratoses: A mechanism-based clinical trial","volume":"24","author":"Maytin","year":"2018","journal-title":"Clin Cancer Res"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.36849\/JDD.5058","article-title":"Dilute intralesional 5-fluorouracil for the treatment of squamous cell carcinomas and keratoacanthomas: A case series","volume":"22","author":"Marka","year":"2023","journal-title":"J Drugs Dermatol"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15139","article-title":"Debulking followed by intralesional 5-fluorouracil for the treatment of cutaneous squamous cell carcinoma and keratoacanthoma: A retrospective analysis","volume":"34","author":"Hamad","year":"2021","journal-title":"Dermatol Ther"},{"key":"B186","article-title":"Comparison of 5% 5-fluorouracil cream and 5% imiquimod cream in the management of actinic keratoses on the face and scalp","volume":"6","author":"Tanghetti","year":"2007","journal-title":"J Drugs Dermatol"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13356","article-title":"Clinical evaluation and efficacy of imiquimod 3.75% cream for the treatment of actinic keratosis, pigmented basal cell carcinomas, and actinic cheilitis","volume":"33","author":"Paolino","year":"2020","journal-title":"Dermatol Ther"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2024.01.065","article-title":"Combination therapy with imiquimod and 5-fluorouracil cream for the treatment of actinic keratoses, a prospective open-label nonrandomized uncontrolled pilot trial","volume":"90","author":"Maxwell Regester","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15800","article-title":"Complete response of locally advanced cutaneous squamous cell carcinoma of the eyelid to topical imiquimod 3.75","volume":"35","author":"Toso","year":"2022","journal-title":"Dermatol Ther"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12800","article-title":"Treatment of actinic keratosis through inhibition of cyclooxygenase-2: Potential mechanism of action of diclofenac sodium 3% in hyaluronic acid 2.5","volume":"32","author":"Thomas","year":"2019","journal-title":"Dermatol Ther"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgad019","article-title":"Diclofenac exhibits cytotoxic activity associated with metabolic alterations and p53 induction in escc cell lines and decreases escc tumor burden","volume":"44","author":"Kabir","year":"2023","journal-title":"vivo. Carcinogenesis"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15868","article-title":"Long-term clinical outcomes of imiquimod 5% cream vs. Diclofenac 3% gel for actinic keratosis on the face or scalp: A pooled analysis of two randomized controlled trials","volume":"34","author":"Gollnick","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B193","first-page":"B5368","article-title":"Exploring the use of ingenol mebutate to prevent non-melanoma skin cancer","volume":"64","author":"Erlendsson","year":"2017","journal-title":"Dan Med J"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-15-0023-T","article-title":"Ingenol mebutate signals via pkc\/mek\/erk in keratinocytes and induces interleukin decoy receptors il1r2 and il13ra2","volume":"14","author":"Freiberger","year":"2015","journal-title":"Mol Cancer Ther"},{"key":"B195","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1177\/12034754221143091","article-title":"Ingenol mebutate is associated with increased reporting odds for squamous cell carcinoma in actinic keratosis patients, a pharmacovigilance study of the fda adverse event reporting system (faers)","volume":"27","author":"Jedlowski","year":"2023","journal-title":"J Cutan Med Surg"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S381471","article-title":"Cemiplimab for the treatment of advanced cutaneous squamous cell carcinoma: Appropriate patient selection and perspectives","volume":"16","author":"Mager","year":"2023","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-008325","article-title":"High response rate with extended dosing of cemiplimab in advanced cutaneous squamous cell carcinoma","volume":"12","author":"Rischin","year":"2024","journal-title":"J Immunother Cancer"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2024.100875","article-title":"Cemiplimab in locally advanced or metastatic cutaneous squamous cell carcinoma: Prospective real-world data from the drug access protocol","volume":"39","author":"Verkerk","year":"2024","journal-title":"Lancet Reg Health Eur"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.1136\/esmoopen-2015-000003","article-title":"A prospective clinical trial to assess lapatinib effects on cutaneous squamous cell carcinoma and actinic keratosis","volume":"1","author":"Jenni","year":"2016","journal-title":"ESMO Open"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.7150\/jca.16850","article-title":"The research on lapatinib in autophagy, cell cycle arrest and epithelial to mesenchymal transition via wnt\/erk\/pi3k-akt signaling pathway in human cutaneous squamous cell carcinoma","volume":"8","author":"Yao","year":"2017","journal-title":"J Cancer"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-0703","article-title":"Inhibition of mammalian target of rapamycin by rapamycin causes the regression of carcinogen-induced skin tumor lesions","volume":"14","author":"Amornphimoltham","year":"2008","journal-title":"Clin Cancer Res"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.1101\/2022.11.03.513568","article-title":"Oral mtor inhibition limits and reduces actinic keratosis and cutaneous squamous cell carcinoma in a uvb-induced mouse model","author":"Booty","year":"2022","journal-title":"bioRxiv"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.01.014","article-title":"Advances in the therapeutic use of mammalian target of rapamycin (mtor) inhibitors in dermatology","volume":"72","author":"Fogel","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2021.02.761","article-title":"Clarifying progress on the genomic landscape of actinic keratosis","volume":"141","author":"Hedberg","year":"2021","journal-title":"J Invest Dermatol"},{"key":"B205","doi-asserted-by":"publisher","DOI":"10.1007\/s10227-001-0041-x","article-title":"The majority of cutaneous squamous cell carcinomas arise in actinic keratoses","volume":"6","author":"Czarnecki","year":"2002","journal-title":"J Cutan Med Surg"},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.3109\/09553002.2012.699697","article-title":"Chronic low dose uv exposure and p53 mutation: Tilting the odds in early epidermal preneoplasia","volume":"88","author":"Roshan","year":"2012","journal-title":"Int J Radiat Biol"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0909738107","article-title":"Stochastic fate of p53-mutant epidermal progenitor cells is tilted toward proliferation by uv b during preneoplasia","volume":"107","author":"Klein","year":"2010","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B208","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.canlet.2019.02.010","article-title":"Uvb drives different stages of epigenome alterations during progression of skin cancer","volume":"449","author":"Yang","year":"2019","journal-title":"Cancer Lett"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.731","article-title":"Does notch play a tumor suppressor role across diverse squamous cell carcinomas","volume":"5","author":"Zhang","year":"2016","journal-title":"Cancer Med"},{"key":"B210","doi-asserted-by":"publisher","DOI":"10.2174\/1574892816666210607092350","article-title":"Targeting notch pathway in cancer diagnostics and therapeutics: An emerging approach","volume":"17","author":"Jain","year":"2022","journal-title":"Recent Pat Anticancer Drug Discovery"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1518633\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T02:15:35Z","timestamp":1737684935000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1518633\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,24]]},"references-count":210,"alternative-id":["10.3389\/fimmu.2025.1518633"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1518633","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,24]]},"article-number":"1518633"}}